March 30, 2009 - The FDA and Watson Pharmaceuticals notified healthcare professionals and patients of a recall of ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
March 30, 2009 - New analysis from the JUPITER study presented at the ACC in Orlando, FL shows that CRESTOR ...
March 30, 2009
March 24, 2009 - Efficacy and safety study results for Corthera's investigational drug relaxin for the ...
March 24, 2009March 20, 2009 - ARCA biopharma Inc., a biopharmaceutical company developing genetically targeted therapies for ...
March 20, 2009March 19, 2009 - The Drug Information Association (DIA), in cooperation with the Heart Rhythm Society (HRS) and ...
March 19, 2009March 19, 2009 - Sanofi-aventis said yesterday the FDA’s Cardiovascular and Renal Drugs Advisory Committee voted ...
March 19, 2009March 18, 2009 - The U.S. Preventive Services Task Force (USPSTF) found that regular aspirin use reduces first ...
March 18, 2009March 17, 2009 - Clinical pharmacology company Cetero Research and centralized cardiac testing company Cardiocore ...
March 17, 2009March 9, 2009 – Merck & Co. Inc. and Schering-Plough Corp. today said their Boards of Directors unanimously ...
March 09, 2009
March 5, 2009 - Bristol-Myers Squibb Company yesterday said it is collaborating with Nissan Chemical Industries ...
March 05, 2009February 25, 2009 - CardioVascular BioTherapeutics Inc. (CVBT) has opened patient enrollment at two additional ...
February 24, 2009February 23, 2009 - Daiichi Sankyo Co. Ltd and Eli Lilly and Co. announced today that the European Commission ...
February 23, 2009
February 19, 2009 - Molecular diagnostic company TrimGen Corp. has received FDA 510(k) clearance to market its eQ ...
February 18, 2009February 12, 2009 - Sanofi-aventis said yesterday the ATHENA trial was published in the New England Journal of ...
February 12, 2009February 3, 2009 - Cerenis Therapeutics SA, a privately held pharmaceutical company developing HDL-related ...
February 03, 2009© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now